水中硝酸盐氮稳定同位素比值测定前处理方法的优化

水体中过量的硝酸盐导致会严重的水生生态恶化和环境污染问题。氮稳定同位素技术为水体污染来源的判断及水生系统氮素转化机理研究提供了强有力的工具。在前人基础上,通过开发Cu2+-Cd复合催化结合超声波辅助加速反应,优化硝酸盐氮同位素比值测定前处理方法。考察了Cu2+添加量,超声功率以及反应时间变化对NO3--N转化生成N2O气体及其氮同位素比值的影响,在单因素实验基础上采用正交实验优化得到了最佳反应条件,并采用不同15N同位素比值的KNO3标准溶液结合气体预浓缩装置与稳定同位素质谱仪联用系统对新方法进行了验证。新方法单次反应体系中氮最低量为1.0 μg,其中自然丰度和高丰度样品δ15N分析精度小于1‰,富集样品的15N分析精度可达0.1 atom%以内(CV<1%);且所有标准样品的15N测定值与参考值基本一致。将优化后的方法应用于不同来源水样中硝酸盐氮稳定同位素比值测定,均可获得较好的精度,较原方法提高了前处理效率,且精度更优。综上,建立的方法准确可靠,操作简单,耗时短,适用于水中硝酸盐氮稳定同位素比值测定的批量、快速前处理。     

N-Butyrylated Hyaluronic Acid Achieves Anti-Inflammatory Effects In Vitro and in Adjuvant-Induced Immune Activation in Rats

Previously synthesized N-butyrylated hyaluronic acid (BHA) provides anti-inflammatory effects in rat models of acute gouty arthritis and hyperuricemia. However, the mechanism of action remains to be elucidated. Herein, the anti-inflammatory and antioxidative activities of BHA and the targeted signaling pathways were explored with LPS-induced RAW264.7 and an adjuvant-induced inflammation in a rat model. Results indicated that BHA inhibited the generation of pro-inflammatory cytokines TNFα, IL-1β and IL-6, reduced ROS production and down-regulated JAK1-STAT1/3 signaling pathways in LPS-induced RAW264.7. In vivo, BHA alleviated paw and joint swelling, decreased inflammatory cell infiltration in paw tissues, suppressed gene expressions of p38 and p65, down-regulated the NF-κB and MAPK signaling pathways and reduced protein levels of TNFα, IL-1β and IL-6 in joint tissues of arthritis rats. This study demonstrated the pivotal role of BHA in anti-inflammation and anti-oxidation, suggesting the potential clinical value of BHA in the prevention of inflammatory arthritis and is worthy for development as a new pharmacological treatment.     

晶格畸变检测仪研究碳化硅晶片中位错缺陷分布

利用晶格畸变检测仪研究了SiC晶片位错分布情况,通过对熔融KOH腐蚀后的SiC晶片进行全片或局部扫描,从而得到完整SiC晶片或局部区域的位错分布.与LEXT OLS40003D激光共聚焦显微镜扫描腐蚀图进行比较,晶格畸变检测仪扫描腐蚀图可以将晶片上位错腐蚀坑信息完全呈现出来,且根据腐蚀坑呈现的颜色及尺寸大小,可以分辨出...     

油品对DMCC甲醛排放的比较研究

为了研究甲醇燃料发动机尾气中甲醛的排放特征,在一台经过改装的组合燃烧发动机上,采用标准测试柴油(TF)和普通市场柴油(MF)进行了实验,比较了燃用不同油料时的甲醛排放特征.实验结果表明;在相同甲醇掺烧比时,两种油料均是在低负荷时甲醛排放最高,在中负荷时最低,在高负荷时甲醛排放居中,三种负荷下MF甲醛排放均比TF高;此外,实验还对比了相同负荷、不同甲醇掺烧比时的甲醛排放,均表现出MF的甲醛排放比TF高,在高负荷下甚至达到2.5倍;实验还表明单纯的依靠氧化催化转化器不能有效降低甲醛排放.     

导电聚苯胺线膜修饰ZnO纳米棒阵列的可控制备及其紫外探测性能

基于p-n结的光生伏特效应可构筑性能优异的UV探测器,本文采用水热法可控制备竖直排列的氧化锌纳米棒阵列(n型ZnO-NRs),利用原位聚合法在ZnO-NRs表面上修饰p型聚苯胺线膜(PANI-NWs),再组装成ZnO-NRs与ZnO-NRs/PANI-NWs紫外探测器.通过扫描电镜(SEM)、X射线衍射仪(XRD)、紫...     

Detoxified pneumolysin derivative ΔA146Ply inhibits autophagy and induces apoptosis in acute myeloid leukemia cells by activating mTOR signaling

Leukemia is caused by the malignant clonal expansion of hematopoietic stem cells, and in adults, the most common type of leukemia is acute myeloid leukemia (AML). Autophagy inhibitors are often used in preclinical and clinical models in leukemia therapy. However, clinically available autophagy inhibitors and their efficacy are very limited. More effective and safer autophagy inhibitors are urgently needed for leukemia therapy. In a previous study, we showed that ΔA146Ply, a mutant of pneumolysin that lacks hemolytic activity, inhibited autophagy of triple-negative breast cancer cells by activating mannose receptor (MR) and toll-like receptor 4 (TLR4) and that tumor-bearing mice tolerated ΔA146Ply well. Whether this agent affects AML cells expressing TLR4 and MR and the related mechanisms remain to be determined. In this study, we found that ΔA146Ply inhibited autophagy and induced apoptosis in AML cells. A mechanistic study showed that ΔA146Ply inhibited autophagy by activating mammalian target of rapamycin signaling and induced apoptosis by inhibiting autophagy. ΔA146Ply also inhibited autophagy and induced apoptosis in a mouse model of AML. Furthermore, the combination of ΔA146Ply and chloroquine synergistically inhibited autophagy and induced apoptosis in vitro and in vivo. Overall, this study provides an alternative effective autophagy inhibitor that may be used for leukemia therapy.Subject terms: Translational research, Acute myeloid leukaemia     

Natural Products in Preventing Tumor Drug Resistance and Related Signaling Pathways

Drug resistance is still an obstacle in cancer therapy, leading to the failure of tumor treatment. The emergence of tumor drug resistance has always been a main concern of oncologists. Therefore, overcoming tumor drug resistance and looking for new strategies for tumor treatment is a major focus in the field of tumor research. Natural products serve as effective substances against drug resistance because of their diverse chemical structures and pharmacological effects. We reviewed the signaling pathways involved in the development of tumor drug resistance, including Epidermal growth factor receptor (EGFR), Renin-angiotensin system (Ras), Phosphatidylinositol-3-kinase/protein kinase B (PI3K/Akt), Wnt, Notch, Transforming growth factor-beta (TGF-β), and their specific signaling pathway inhibitors derived from natural products. This can provide new ideas for the prevention of drug resistance in cancer therapy.     

3英寸6H-SiC单晶的生长

SiC是宽带隙半导体材料的典型代表,具有优良的热学、力学、化学和电学性质,不但可以用作基于GaN的蓝色发光二极管的衬底材料,同时又是制作高温、高频、大功率电子器件的最佳材料之一,因此高质量、大直径SiC单晶的生长一直是材料研究领域的热点课题。目前美国的Cree公司在SiC单晶生长领域研发方面起步早、投入大,SiC单晶的直径达到4英寸,处于领先地位。我国在“十五”期间投入了一定的人力、物力进行了SiC单晶生长的研究,在生长2英寸SiC单晶的工作中取得了一定的成绩[1],但更大直径的SiC单晶生长技术进展缓慢,至今未见国内报道。而对…     

Metabolic Engineering of Shikimic Acid Biosynthesis Pathway for the Production of Shikimic Acid and Its Branched Products in Microorganisms: Advances and Prospects

The shikimate pathway is a necessary pathway for the synthesis of aromatic compounds. The intermediate products of the shikimate pathway and its branching pathway have promising properties in many fields, especially in the pharmaceutical industry. Many important compounds, such as shikimic acid, quinic acid, chlorogenic acid, gallic acid, pyrogallol, catechol and so on, can be synthesized by the shikimate pathway. Among them, shikimic acid is the key raw material for the synthesis of GS4104 (Tamiflu^®), an inhibitor of neuraminidase against avian influenza virus. Quininic acid is an important intermediate for synthesis of a variety of raw chemical materials and drugs. Gallic acid and catechol receive widespread attention as pharmaceutical intermediates. It is one of the hotspots to accumulate many kinds of target products by rationally modifying the shikimate pathway and its branches in recombinant strains by means of metabolic engineering. This review considers the effects of classical metabolic engineering methods, such as central carbon metabolism (CCM) pathway modification, key enzyme gene modification, blocking the downstream pathway on the shikimate pathway, as well as several expansion pathways and metabolic engineering strategies of the shikimate pathway, and expounds the synthetic biology in recent years in the application of the shikimate pathway and the future development direction.